# Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)

> **NCT00433888** · PHASE3 · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 179 (actual)

## Conditions studied

- Hemodialysis Patients

## Interventions

- **DRUG:** R744
- **DRUG:** R744

## Key facts

- **NCT ID:** NCT00433888
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-10
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2009-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00433888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00433888, "Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00433888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*